Anabolic Steroids - a Review of the Clinical Toxicology and Diagnostic Screening

References

• Buckley W E, Yesalis C E, Friedl K E, Anderson W A, Streit A L, Wright J E. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 1988; 260: 3441–5
   PubMed Web of Science ®Google Scholar
• Johnson M D, Jay M S, Shoup B, Rickert VI. Anabolic steroid use by male adolescents. Pediatrics 1989; 83: 921–4
   PubMed Web of Science ®Google Scholar
• Windsor R, Dumitru D. Prevalence of anabolic steroid use by male and female adolescents. Med Sci Sports Exerc 1989; 21: 494–497
   PubMed Web of Science ®Google Scholar
• Yesalis C E, Herrick R T, Buckley W E, Friedl K E, Brannon D, Wright J E. Self-reported use of anabolic-androgenic steroids by elite power-lifters. The Physician and Sports Medicine 1988; 16: 91–100
   PubMed Web of Science ®Google Scholar
• Tennant F, Black D L, Voy R O. Anabolic steroid dependence with opioid-type features. N Eng J Med 1988; 319: 578
   PubMed Web of Science ®Google Scholar
• Brower K F, Blow F L, Beresford T P, Fuelling C. Anabolic-androgenic steroid dependence. J Clin Psychiatry 1989; 50: 31–3
   PubMed Web of Science ®Google Scholar
• Kashkin K B, Kleber H D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA 1989; 262: 3166–70
   PubMed Web of Science ®Google Scholar
• Bowman S J, Tanna S, Fernando S, Ayodeji A, Weatherbone R M. Anabolic steroids and infarction. Br Med J 1989; 299: 632
   Google Scholar
• Mc Nutt R A, Ferenchick G S, Kirlin P C, Hamlin N J. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988; 62: 164
   PubMed Web of Science ®Google Scholar
• Capezzuto A, Achilli A, Serra N. Myocardial infarction in a 21-yearold body builder. Am J Cardiol 1989; 63: 1539
   PubMed Web of Science ®Google Scholar
• Frankle M A, Eichberg R, Zachariah S B. Anabolic androgenic steroids and a stroke in an athlete. Arch Phys Med Rehabil 1988; 69: 632–3
   PubMed Web of Science ®Google Scholar
• Nagelberg S B, Laue L, Loriaux D L, Liu L, Sherns R J. Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man. N Engl J Med 1986; 314: 649–50
   PubMed Web of Science ®Google Scholar
• Lubell A. Does steroid abuse cause - or excuse - violence?. The Physician and Sports Medicine 1989; 17: 176–85
   PubMed Web of Science ®Google Scholar
• Conacher G N, Workman D G. Violent crime possibly associated with anabolic steroid use. Am J Psychiatry 1989; 146: 679
   PubMed Web of Science ®Google Scholar
• Pope H G, Katz D L. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 1989; 51: 28–31
   Web of Science ®Google Scholar
• de Morode Prince A. Doping tests at the Olympic Games in 1976. J Sports Med 1976; 19: 91–6
   Google Scholar
• National Collegiate Athletic Association. The 1988—89 NCAA drug-testing program. National Collegiate Athletic Association, Mission, KS 1988
   Google Scholar
• Wadler G I, Hainline B. Drugs and the Athlete. F.A. Davis, Philadelphia 1989; 288–334
   Google Scholar
• Catlin D H. Detection of drug use by athletes. Drugs and Performance in Sports, R H Strauss. W.B. Saunders, Philadelphia 1978; 103–20
   Google Scholar
• Haupt H A, Rovere G D. Anabolic steroids: a review of the literature. Am J Sports Med 1984; 12: 469–84
   PubMed Web of Science ®Google Scholar
• Murad F, Haynes R, Androgens C. Goodman and Gilman's the Pharmacological Basis of Therapeutics. 7th ed, A G Gilman, L S Goodman, T W Rall, et al. MacMillan, New York 1985; 1440–58
   Google Scholar
• Freed D IJ, Banks A J, Longson D, et al. Anabolic steroids in athletes: crossover double-blind trial on weightlifters. Br Med J 1975; 2: 471–3
   PubMed Web of Science ®Google Scholar
• Lamb D R. Anabolic steroids in athletes: how well do they work and how dangerous are they?. Am J Sports Med 1984; 12: 31–8
   PubMed Web of Science ®Google Scholar
• Ariel G, Saville W. Anabolic steroids: the physiological effects of placebos. Med Sci Sports 1972; 4: 124–6
   Google Scholar
• Alen M, Hakkinen K, Komi P V. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids. Acta Physiol Scand 1984; 122: 535–44
   PubMedGoogle Scholar
• Crist D M, Stackpole P J, Peake G T. Effects of androgenic-anabolic steroids on neuromuscular power and body composition. J Appl Physiol 1983; 54: 366–70
   PubMed Web of Science ®Google Scholar
• Fahey T D, Brown C H. The effects of an anabolic steroid on the strength, body composition, and endurance of college males when accompanied by a weight training program. Med Sci Sports 1973; 5: 272–6
   PubMedGoogle Scholar
• Hervey G R, Hutchinson I, Knibbs A V, et al. “Anabolic” effects of methadione in men undergoing athletic training. Lancet 1976; 2: 699–702
   PubMed Web of Science ®Google Scholar
• Shepard R J, Killinger D, Fried T. Responses to sustained use of anabolic steroids. Br J Sports Med 1977; 11: 170–3
   PubMedGoogle Scholar
• Windsor R E, Dumitru D. Anabolic steroid use by athletes. Postgrad Med 1988; 84: 37–49
   PubMed Web of Science ®Google Scholar
• Haupt H A. Drugs in athletics. Clin Sports Med 1989; 8: 561–82
   PubMed Web of Science ®Google Scholar
• Gall S L, Duda M, Giel D, Christian Rogers C. Who tests which athletes for what drugs?. The Physician and Sports Medicine 1988; 16: 155–61
   Google Scholar
• Wagner J C. Substance abuse policies and guidelines in amateur and professional athletics. Am J Hosp Pharm 1987; 44: 305–10
   PubMedGoogle Scholar
• Shroyer J. Getting tough on anabolic steroids: can we win the battle?. The Physician and Sports Medicine 1990; 18: 106–18
   PubMed Web of Science ®Google Scholar
• Anon. Anabolic steroids (systemic), Androgens (systemic). USP DI: Drug Information for the Health Care Professional. The United States Pharmacopeial Convention, Inc., Rockville, MD 1990; Volume I-A: 194–206
   Google Scholar
• Hickson R C, Ball K L, Falduto M T. Adverse effects of anabolic steroids. Med Toxicol Adverse Drug Exp 1989; 4: 254–71
   PubMedGoogle Scholar
• Kibble M W, Ross M B. Adverse effects of anabolic steroids in athletes. Clin Pharmacy 1987; 6: 686–92
   PubMedGoogle Scholar
• Pope H G, Katz D L. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 1988; 145: 487–90
   PubMed Web of Science ®Google Scholar
• Wilson J D. Androgen abuse by athletes. Endocrin Rev 1988; 9: 181–99
   PubMed Web of Science ®Google Scholar
• Macintyre J G. Growth hormone and athletes. Sports Med 1987; 4: 129–42
   PubMed Web of Science ®Google Scholar
• Kiraly C L, Alen M, Rahkila P, Horsmanheimo M. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. Acta Derm Venereol 1987; 67: 36–40
   PubMed Web of Science ®Google Scholar
• Kiraly C L, Alen M, Korvola J, Horsmanheimo M. The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men. Acta Derm Venereol 1988; 68: 21–6
   PubMed Web of Science ®Google Scholar
• Kiraly C L, Collan Y, Alen M. Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. Am J Dermatopathol 1987; 9: 515–9
   PubMed Web of Science ®Google Scholar
• Scott M J, Jr, Scott M J. Dermatologist and anabolic-androgenic drug abuse. Cutis 1989; 44: 30–5
   PubMed Web of Science ®Google Scholar
• Overly W L, Dankoff J A, Wang B K, Singh U D. Androgens and hepatocellular carcinoma in an athlete (letter). Ann Intern Med 1984; 100: 158–9
   PubMed Web of Science ®Google Scholar
• Stang-Voss C, Appell H J. Structural alterations of liver parenchyma induced by anabolic steroids. Int J Sports Med 1981; 2: 101–5
   PubMed Web of Science ®Google Scholar
• Goldman B. Liver carcinoma in an athlete taking anabolic steroids (letter). J Am Osteopath Assoc 1985; 85: 56
   PubMedGoogle Scholar
• Creagh T M, Rubin A, Evans D J. Hepatic tumors induced by anabolic steroids in an athlete. J Clin Pathol 1988; 41: 441–3
   PubMed Web of Science ®Google Scholar
• Mc Killop G, Todd I C, Ballantyne D. Increased left ventricular mass in a body builder using anabolic steroids. Br J Sports Med 1986; 20: 151–2
   PubMedGoogle Scholar
• Urhausen A, Holpes R, Kindermann W. One and two-dimensional echocardiography in body builders using anabolic steroids. Eur J Appl Physiol 1989; 58: 633–40
   Web of Science ®Google Scholar
• Zuliani U, Bernardini B, Catapano A, Compana M, Cerioli G, Spattini M. Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders. Int J Sports Med 1989; 10: 62–6
   PubMed Web of Science ®Google Scholar
• Kleiner S M, Calabrese L H, Fielder K M, Naito H K, Skibinski C I. Dietary influences on cardiovascular disease risk in anabolic steroidusing and nonusing bodybuilders. J Am Coll Nutr 1989; 8: 109–19
   PubMed Web of Science ®Google Scholar
• Holma P, Adlercreutz H. Effect of an anabolic steroid (metandienon) on plasma LH-FSH, and testosterone and on the response to intravenous administration of LRH. Acta Endicrinol 1976; 83: 856–64
   PubMedGoogle Scholar
• Alen M, Rahkila P, Reinila M, Vihko R. Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes. Am J Sports Med 1987; 15: 357–61
   PubMed Web of Science ®Google Scholar
• Alen M. Androgenic steroid effects on liver and red cells. Br J Sports Med 1985; 19: 15–20
   PubMedGoogle Scholar
• McKillop G, Ballantyne D. Lipoprotein analysis in bodybuilders. Int J Cardiol 1987; 17: 281–8
   PubMed Web of Science ®Google Scholar
• Alen M, Rahkila P. Reduced high-density-lipoprotein-cholesterol in power athletes: use of male sex hormone derivatives, an atherogenic factor. Int J Sports Med 1984; 5: 341–2
   PubMed Web of Science ®Google Scholar
• Alen M, Rahkila P, Marniemi J. Serum lipids in power athletes self administering testosterone and anabolic steroids. Int J Sports Med 1985; 6: 139–44
   PubMed Web of Science ®Google Scholar
• Lenders J W, Demacker P N, Vos J A, et al. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med 1988; 9: 19–23
   PubMed Web of Science ®Google Scholar
• Cohen J C, Hickman R. Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987; 64: 960–3
   PubMed Web of Science ®Google Scholar
• Clerico A, Fefeghini M, Palombo C, et al. Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training. J Nucl Med Allied Sci 1981; 25: 79–88
   PubMedGoogle Scholar
• Ruokonen A, Alen M, Bolton N, Vihko R. Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. J Steroid Biochem 1985; 23: 33–8
   PubMedGoogle Scholar
• Hurley B F, Seals D R, Hagberg J M, et al. High-density-lipoprotein cholesterol in bodybuilders and powerlifters: negative effects of androgen use. JAMA 1984; 252: 507–13
   PubMed Web of Science ®Google Scholar
• Webb O L, Laskarzewski P M, Glueck C T. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolicandrogenic steroids. Metabolism 1984; 33: 971–5
   PubMed Web of Science ®Google Scholar
• Alen M, Rahkila P. Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes. Sports Med 1988; 6: 327–32
   PubMed Web of Science ®Google Scholar
• Hatton C K, Catlin D H. Detection of androgenic anabolic steroids in urine. Clinics in Laboratory Medicine 1987; 7: 655–68
   PubMed Web of Science ®Google Scholar
• Annitto W J, Layman W A. Anabolic steroids and acute schizophrenic episode. J Clin Psychiatry 1980; 41: 143–144
   PubMed Web of Science ®Google Scholar
• Hallagan J B, Hallagan L F, Synder M B. Anabolic-androgenic steroid use by atheletes: Sounding board. N Eng J Med 1989; 321: 1042–1045
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual 3rd Edition. American Psychiatric Association. 1988, Revised
   Google Scholar
• Heasen M, Kazdin A E, Bellack A S. The Clinical Psychology Handbook. Pergamon Press, Inc. 1983
   Google Scholar
• Walsh M, Mellin M, Shelton G. Team Physicians Handbook. Williams & Wilkins, Baltimore 1990; 95–110
   Google Scholar
• Psychological Testing. 6th Edition. Macmillan Publishing Company. 1988
   Google Scholar
• Salock K. Comprehensive Textbook of Psychiatry, 4th Edition. Williams & Wilkins Publishers, Baltimore 1990
   Google Scholar
• Nideffer R M. The Ethics: Practice of Applied Sport Psychology. Ithaca, NY 1981
   Google Scholar
• Orlick T. In Pursuit of Excellence. Human Kinetics, Champaign, IL 1980
   Google Scholar
• Hathaway S R, McKinley J C. The Minnesota Multiphasic Personality Inventory manual. Psychological Corp, New York 1967
   Google Scholar
• Cattell R B, Eber H W, Tatsuoka M M. Handbook for the Sixteen Personality Factor Questionnaire. Institute for Personality Testing, Champaign, IL 1970
   Google Scholar
• Millon T, Green C J, Meagher R B. Millon Behavioral Health Inventory Manual. National Computer Systems, Minneapolis 1982
   Google Scholar
• Rorschach H. Psychodiagnostics. Bircher, Bern 1921, 1942.Trans by Hans Huber Vergal
   Google Scholar
• Exner J E. The Rorschach: A Comprehensive System. John Wiley, New York 1986; Vol 1
   Google Scholar
• Beck A T, Steer R A. Beck Depression Inventory manual. Psychological Corp, New York 1987
   Google Scholar
• Spielberger C D, Gorsuch R L, Lushene R, Vagg P R, Jacobs G A. The State-Trait Anxiety Inventory manual. Consulting Psychologists Press, Palo Alto 1983
   Google Scholar
• Gough H G, Heilburn A B. The Adjective Check List manual. Consulting Psychologists Press, Palo Alto 1980
   Google Scholar
• Mc Nair D M, Lorr M, Droppleman L F. Profile of Mood States. Educational and Industrial Testing Service, San Diego 1971
   Google Scholar
• Martens R. Sport Competition Anxiety Test. Human Kinetics, Champaign, IL 1977
   Google Scholar
• Wagner J C. Abuse of drugs used to enhance athletic performance. Am J Hosp Pharm 1989; 46: 2059–67
   PubMedGoogle Scholar
• Kleber H D, Topazian M, Gaspari J, Riordan C E, Kosten T. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse 1987; 13: 1–17
   PubMed Web of Science ®Google Scholar